1

Click here to load reader

4506017 Modified Pasteurella haemolytica bacteria

  • Upload
    voque

  • View
    218

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 4506017 Modified Pasteurella haemolytica bacteria

PATENT ABSTRACTS

4504547

P R O C E S S F O R P R O D U C I N G S U P P O R T S F O R C E L L

C U L T U R E S A N D S U P P O R T S S O O B T A I N E D

Florian Horodniceanu, Raphael Le Fur, Meudon, France assigned to Institut Pasteur

The present invention relates to the use of thermosetting plastics for improving supports used for cell growth. The process according to the invention consists of applying to base sup- ports, a solution of a thermosetting plastics material and of then subjecting the thus-coated supports to the effect of heat under conditions sufficient to permit the hardening of the thermo- setting plastics material and sterilization of the thus-coated supports. The supports according to the invention are suitable for any conventional seeding and trypsination operations on cell cul- tures; they can also be used for the cultivation of human or animal diploid cells.

4505892

I N F E C T I O U S B R O N C H I T I S V A C C I N E F O R P O U L T R Y

Pete Apontoweil, Manfred Krasselt, Leersum, Netherlands assigned to Gist-Brocades N V

141

Infectious bronchitis (IB) vaccines for poultry derived from at least one novel virus strain of novel infectious bronchitis serotypes, selected from the group consisting of culture Nos. CNCTC A 07/80, CNCTC A 08/80, CNCTC A 09/80, CNCTC A 010/80, CNCTC A 011/80, CNCTC A 013/80, CNCTC A 014/80, CNCTC A 015/80 and CNCTC A 016/80 deposited at the Czechoslovak National Collection of Type Cul- tures of the Institute of Hygiene and Epi- demiology in Prague, Czechoslovakia and the novel viruses per se, combined virus vaccaines and a novel method of protecting poultry from infectious bronchitis.

4506017

M O D I F I E D P A S T E U R E L L A H A E M O L Y T I C A B A C T E R I A

Carrell Kucera assigned to Norden Laboratories Inc

The chemical modification of virulent Pasteurella multocida and Pasteurella haemolytica strains and preparation of live bac- teria vaccines from the modified organisms for immunization of bovine, porcine and ovine animal species are disclosed.